The Phase 3 portion of the Orbit study for UX143 shows progress and is on track for a final analysis by the end of the year, suggesting effective management of the clinical trial timeline. The Data ...
THE WOODLANDS, Texas, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has enrolled the first patient in PROGRESS (A Phase 2b, Dose-ranging, ...
GREENVILLE, N.C. (WNCT) — AAA released their latest research about pedestrian crashed at nighttime recently. The study shows major progress in vehicle safety technology. They said that pedestrian ...
"Anytime I talk to other women, either different professors or just students here, and I tell them that I'm researching recurrent urinary tract infections, they're like, 'Oh my God, please find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results